[ Price : $8.95]
Caranx Medical files a PMA for its TAVIpilot AI Software for real-time intra-operative guidance of transcatheter heart valve impla...[ Price : $8.95]
ALX Oncology plans to discuss with FDA its path for seeking accelerated approval for CD47-blocker evorpacept based on positive upd...[ Price : $8.95]
FDA approves a Medexus NDA for Grafapex (treosulfan) for use with fludarabine as a preparative regimen for allogeneic hematopoiet...[ Price : $8.95]
Responding to a Trump Administration order, FDA delays the effective date until 3/21 of a recent final rule entitled Nonprescripti...[ Price : $8.95]
HHS elevates CDRH chief medical officer for in vitro diagnostics Sara Brenner to FDA acting commissioner under the Trump Administr...[ Price : $8.95]
Merck and Eisai say results from the Phase 3 LEAP-015 trial evaluating Keytruda plus Lenvima in gastroesophageal adenocarcinoma pa...[ Price : $8.95]
FDA will review a Biogen sNDA for a Spinraza higher dose regimen.[ Price : $8.95]
FDA removes information and documents regarding several diversity-related initiatives and policies, presumably in response to a Tr...